GENOMIC ANALYSIS OF THE F-SUBTYPES OF HUMAN-COMPLEMENT FACTOR-B

被引:12
作者
JAHN, I
MEJIA, JE
THOMAS, M
DARKE, C
SCHRODER, H
GESERICK, G
HAUPTMANN, G
机构
[1] NATL BLOOD TRANSFUS SERV, REG TISSUE TYPING LAB, CARDIFF, S GLAM, WALES
[2] HUMBOLDT UNIV BERLIN, INST GERICHTLICHE MED, BERLIN, GERMANY
来源
EUROPEAN JOURNAL OF IMMUNOGENETICS | 1994年 / 21卷 / 06期
关键词
D O I
10.1111/j.1744-313X.1994.tb00214.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Factor B of human complement is encoded within the Major Histocompatibility Complex (MHC) and is polymorphic, with up to 30 alleles defined by electrophoretic mobility. One of the most common alleles, BF*F, is subdivided into the FA and FB subtypes, which differ at the gene level by non-synonymous base substitutions in the seventh codon. We have found at this position a new restriction site polymorphism, as a Bsl I site absent from the FB allele. Using this restriction polymorphism, we have developed a method for BF F subtype determination, based on amplification by polymerase chain reaction of the 5' end of the BF gene, and digestion with Bsl I. This new method has been applied to a panel of 29 selected BF F individuals. A single strand DNA conformation analysis of the same region of the gene allowed us to confirm the above DNA-based BF F subtyping. During this study, two BF*F1 alleles showed discrepancies between protein and DNA typing, which were confirmed by our sequencing data. These were identical, in the 5' region, to BF*S and BF*FB genes, respectively. In a comparison with two protein subtyping methods, identical results were found for only one third of the selected samples. The conflicting results may arise, in part, from previously undescribed molecular heterogeneity within BF F subtypes, or from the presence of a null allele. Our new method allows FF*F subtyping to be used with confidence in the definition of disease-associated MHC haplotypes.
引用
收藏
页码:415 / 423
页数:9
相关论文
共 28 条
[21]   PRIMER-DIRECTED ENZYMATIC AMPLIFICATION OF DNA WITH A THERMOSTABLE DNA-POLYMERASE [J].
SAIKI, RK ;
GELFAND, DH ;
STOFFEL, S ;
SCHARF, SJ ;
HIGUCHI, R ;
HORN, GT ;
MULLIS, KB ;
ERLICH, HA .
SCIENCE, 1988, 239 (4839) :487-491
[22]   DNA SEQUENCING WITH CHAIN-TERMINATING INHIBITORS [J].
SANGER, F ;
NICKLEN, S ;
COULSON, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (12) :5463-5467
[23]   THE BF F-SUBTYPES ARE DETECTABLE IN THE BA FRAGMENT OF FACTOR-B [J].
SIEMENS, I ;
BENDER, K ;
GESERICK, G ;
MAUFF, G ;
PULVERER, G .
FORENSIC SCIENCE INTERNATIONAL, 1989, 42 (03) :279-286
[24]   IMPROVEMENT OF BF TYPING AND OF BF F-SUBTYPING AFTER NEURAMINIDASE TREATMENT IN THE UNCONVERTED AND CONVERTED FACTOR-B [J].
SIEMENS, I ;
GESERICK, G ;
MAUFF, G ;
CORRENS, A ;
SCHRODER, H .
ELECTROPHORESIS, 1992, 13 (06) :367-372
[25]   SUBTYPING OF PROPERDIN FACTOR-B (BF) BY ISOELECTROFOCUSING [J].
TENG, YS ;
TAN, SG .
HUMAN HEREDITY, 1982, 32 (05) :362-366
[26]  
THOMAS MW, 1992, EUR J IMMUNOGENET, V19, P454
[27]   CELL-SPECIFIC EXPRESSION OF THE HUMAN-COMPLEMENT PROTEIN FACTOR-B GENE - EVIDENCE FOR THE ROLE OF 2 DISTINCT 5'-FLANKING ELEMENTS [J].
WU, LC ;
MORLEY, BJ ;
CAMPBELL, RD .
CELL, 1987, 48 (02) :331-342
[28]   NONISOTOPIC SSCP DETECTION IN PCR PRODUCTS BY ETHIDIUM-BROMIDE STAINING [J].
YAP, EPH ;
MCGEE, JO .
TRENDS IN GENETICS, 1992, 8 (02) :49-49